Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2005
11/17/2005US20050255548 Protein scaffolds for antibody mimics and other binding proteins
11/17/2005US20050255532 Antibodies that immunospecifically bind to B lymphocyte stimulator
11/17/2005US20050255527 screening for biological targets, using a combination of an enyzyme-linked immunoassay and electrochemiluminescence assay to identify antibodies or antigen binding fragments
11/17/2005US20050255519 Reagents and methods useful for detecting diseases of the prostate
11/17/2005US20050255502 Screening agents which modulate formation of FANCD2-containing foci; cell expressing polynucleotide comprising DNA sequence encoding protein
11/17/2005US20050255496 Ztnf12, a tumor necrosis factor
11/17/2005US20050255470 determining the GPVI allelotype of subjects in need of surgery, with a low platelet count, with an acquired bleeding disorder, on blood thinning drugs, or of blood donors; diagnosis of an increased risk of bleeding
11/17/2005US20050255125 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
11/17/2005US20050255122 particularly, preventing or ameliorating the neuropathology of Alzheimer's disease, by administering an A beta peptide having a specific amino acid sequence and an adjuvant that enhances the immune response
11/17/2005US20050255120 Composition and method for introduction of DNA directed RNA interference sequences into targeted cells and tissues
11/17/2005US20050255119 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
11/17/2005US20050255118 Methods and composition for treating tumors and metastatic disease
11/17/2005US20050255117 Administering an antibody to specifically bind an epitope in the cysteine-rich domain of Cripto protein; binding to an epitope in the ligand/receptor binding domain of either a native or denatured form; binding to an epidermal growth factor-like domain; angiogenesis inhibitors; antitumor agents
11/17/2005US20050255116 Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer
11/17/2005US20050255115 T-cell surface glycoprotein specific immunoglobulin for use in treatment and prevention of cell proliferative disorders; immunotherapy
11/17/2005US20050255114 Methods and diagnosis for the treatment of preeclampsia
11/17/2005US20050255113 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders
11/17/2005US20050255112 Compositions and methods for preventing erythropoietin-associated hypertension
11/17/2005US20050255111 Use of an inhibitor or antagonist against tissue factor
11/17/2005US20050255110 Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies
11/17/2005US20050255109 Methods and compositions for inhibition of metastasis
11/17/2005US20050255108 For improving clinical outcome in focal ischemic stroke in a mammal by increasing cerebral blood flow and/or reducing infarct size in absence of removal of the arterial obstruction; administering anti-CD18 antibody
11/17/2005US20050255107 Anti-angiogenic proteins and fragments and methods of use thereof
11/17/2005US20050255106 Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40
11/17/2005US20050255105 Severe myelin deficits induced by self-reactive gamma delta T cells
11/17/2005US20050255104 administering antibodies or antigen-binding fragments which are specific for human tumor necrosis factor- alpha (TNF alpha), used for in vivo medical diagnosis and therapy; immunoassay and immunotherapy
11/17/2005US20050255103 Remedy for lung cancer
11/17/2005US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation
11/17/2005US20050255101 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/17/2005US20050255100 Isolated nucleic acid encoding a human polypeptide, tumor necrosis factor receptor-5; tumor necrosis factor blocking agent; cyclosporine immunosuppressant; antibiotic; anti-inflammatory; graft versus host disease, viral infection, cancer, leukemia, immunodeficiency, autoimmune disorder
11/17/2005US20050255098 Methods of treating traumatic spinal cord injury
11/17/2005US20050255089 adeno-associated virus 5 (AAV5) specific polynucleotides, that codes for an AAV5 specific proteins; delivering polynucleotides to cells using the AAV5 vectors and particles
11/17/2005US20050255083 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2005US20050255041 Administering monoclonal antibody or antigen binding fragment accession number 270404-01; primary and metastatic tumors
11/17/2005CA2566344A1 Mutant pneumolysin proteins
11/17/2005CA2566041A1 T-type calcium channel splice variant compositions and methods
11/17/2005CA2565215A1 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients
11/17/2005CA2563516A1 Monoclonal antibody sc104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
11/17/2005CA2563334A1 Assay for antibodies
11/17/2005CA2563080A1 Monoclonal antibodies to hepatocyte growth factor
11/17/2005CA2561684A1 Real time method of detecting acute inflammatory conditions
11/17/2005CA2560865A1 Cancer associated antigens
11/16/2005EP1595959A1 Method for enhancing efficacy of preparation of monoclonal antibody
11/16/2005EP1595955A1 Beta 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same
11/16/2005EP1595951A1 Diagnosis and treatment of diseases using peptides which are bound by specific anti-anti-t-cell receptor vbeta antibodies
11/16/2005EP1595947A1 MN gene and protein
11/16/2005EP1595145A2 Methods for the treatment of renal cell carcinoma
11/16/2005EP1594989A2 Methods for the early diagnosis of ovarian cancer
11/16/2005EP1594988A2 Method of diagnosis of type 2 diabetes and early onset thereof
11/16/2005EP1594969A2 Active immunization to generate antibodies to soluble a-beta
11/16/2005EP1594958A2 Activation and expansion of cells
11/16/2005EP1594900A2 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
11/16/2005EP1594899A1 Idiotypic vaccine
11/16/2005EP1594898A2 Glycosylated specificity exchangers
11/16/2005EP1594897A2 Use of il-6 antagonists in combination with steroids to enhance apoptosis
11/16/2005EP1594892A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
11/16/2005EP1594891A1 Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof
11/16/2005EP1594888A2 Tolerance-induced targeted antibody production
11/16/2005EP1594561A2 Yersinia species compositions
11/16/2005EP1594548A1 Anthracycline-antibody conjugates
11/16/2005EP1594543A2 Immunogene adherence and method of making and using the same
11/16/2005EP1594542A2 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
11/16/2005EP1594541A2 Method and compositions for the treatment of meconium aspiration syndrome
11/16/2005EP1594533A2 Antibody vaccine conjugates and uses therefor
11/16/2005EP1594444A2 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/16/2005EP1594441A2 Method for treating pain by administering a nerve growth factor antagonist and an nsaid and composition containing the same
11/16/2005EP1594439A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
11/16/2005EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/16/2005EP1581559A3 Fc fusion
11/16/2005EP1294927B1 Screening-method for modulators of methyltransferase-dependent chromosome stability
11/16/2005EP1206550B1 Proteins derived from white spot syndrome virus and uses thereof
11/16/2005EP1131090B1 Use of paraoxanase-1 (pon-1) to decrease atheroma formation and hypercholesterolemia
11/16/2005EP1100515B1 EX VIVO TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS
11/16/2005EP1068328B1 Treatment and diagnosis of staphylococcal infections
11/16/2005EP1062235B1 A method for isolating and purifying soluble proteins and peptides from plant sources
11/16/2005EP0871703B1 Dna encoding glutamate gated chloride channels
11/16/2005EP0741745B1 Hepatitis b vaccine
11/16/2005CN1697973A Immunoassay
11/16/2005CN1696157A Method for preparing polyclonal antibody of ascites from anti aflatoxin B1 of rat
11/16/2005CN1227533C Reagent for diagnosing cardiac infarction
11/16/2005CN1227359C Down-regualtion resistant C3 convertase
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227264C Immunogenic peptides derived from MAGE and use thereof
11/16/2005CN1227033C Method of treating cancer with anti-neurotrophin agents
11/15/2005US6965024 Reactive with ganglioside GD3; cancer treatment
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods
11/15/2005US6965016 Antagonist for use in the prevention of fertility in humans and animals
11/15/2005US6965015 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/15/2005US6965014 Bioerodible film; mixture of thrombin and fibrinogen; controlling coagulation; drug delivery of antitumor, anticancer agents
11/15/2005US6965009 p53 as protein and antibody therefor
11/15/2005US6964854 Using monoclonal antibody; hybridomas cell line
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005US6964852 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
11/15/2005US6964849 Proteins and nucleic acids encoding same
11/15/2005US6964770 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
11/15/2005US6964768 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
11/15/2005US6964767 Polypeptides; detecting infections using antibodies
11/15/2005US6964199 Methods and compositions for enhanced protein expression and/or growth of cultured cells using co-transcription of a Bcl2 encoding nucleic acid
11/15/2005CA2302360C Fluorination of proteins and peptides for f-18 positron emission tomography
1 ... 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 ... 1494